We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

39 hedge funds and large institutions have $18.6M invested in Achieve Life Sciences in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

225% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $421K

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

26% more funds holding

Funds holding: 31 → 39 (+8)

12% more capital invested

Capital invested by funds: $16.6M → $18.6M (+$1.97M)

3.21% more ownership

Funds ownership: 13.78% → 16.99% (+3.2%)

Holders
39
Holders Change
+8
Holders Change %
+25.81%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
14
Reduced
10
Closed
3
Calls
$1.37M
Puts
$421K
Net Calls
+$948K
Net Calls Change
-$955K

Top Buyers

Rank Fund Capital Flow
1
SC
Shay Capital
New York
+$2.08M
2
AIC
AWM Investment Company
New York
+$1.91M
3
BRWA
B. Riley Wealth Advisors
Florida
+$1.52M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.11M
5
OGC
One68 Global Capital
New York
+$678K

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$990K
2
Group One Trading
Group One Trading
Illinois
-$867K
3
LFCM
Long Focus Capital Management
Puerto Rico
-$457K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$128K
5
PCM
Perkins Capital Management
Minnesota
-$77.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
26
Manchester Financial
California
$67.1K +$90.6K +12,925 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$59.4K -$1.62K -231 -2%
CH
28
CVI Holdings
Delaware
$58.1K +$78.6K +11,200 New
Bank of America
29
Bank of America
North Carolina
$33.8K +$45.7K +6,519 New
BWM
30
BerganKDV Wealth Management
Minnesota
$25.9K +$35.1K +5,000 New
Osaic Holdings
31
Osaic Holdings
Arizona
$23.1K +$13.4K +1,909 +75%
Belvedere Trading
32
Belvedere Trading
Illinois
$21.6K -$40.3K -5,750 -58%
Morgan Stanley
33
Morgan Stanley
New York
$19.7K – – –
SC
34
Stephens Consulting
Michigan
$15.6K – – –
Simplex Trading
35
Simplex Trading
Illinois
$10K +$3.72K +530 +35%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$3K +$3.51K +500 New
GGI
37
Godsey & Gibb Inc
Virginia
$2.35K – – –
CG
38
Cutler Group
California
$2K -$4.36K -621 -56%
UBS Group
39
UBS Group
Switzerland
$862 -$3.93K -560 -77%
IC
40
Ikarian Capital
Texas
– -$990K -174,714 Closed
BAM
41
Belpointe Asset Management
Nevada
– -$13.6K -2,000 Closed
JP Morgan Chase
42
JP Morgan Chase
New York
– -$1.7K -250 Closed
1
2

ACHV Hedge Fund Activity: Q2 2023 in Review

39 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q2 2023, worth a combined $18.6M — up 12% from $16.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ACHV positions and 3 closed out — a net gain of 8 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was Shay Capital, adding an estimated $2.08M. The largest seller was Ikarian Capital, exiting entirely with an estimated $990K sold.

  • 39 institutional investors held Achieve Life Sciences (ACHV) as of Q2 2023, up from 31 in Q1 2023.
  • Funds reported $18.6M of Achieve Life Sciences stock for Q2 2023, up 12% quarter-over-quarter.
  • 11 funds opened new Achieve Life Sciences positions in Q2 2023 and 3 closed out, a net change of +8 holders.
  • The largest Achieve Life Sciences buyer in Q2 2023 was Shay Capital, an estimated $2.08M added.
  • The largest Achieve Life Sciences seller in Q2 2023 was Ikarian Capital, an estimated $990K sold.

Based on aggregated 13F filings for Q2 2023.